PARASHLTH
Paras Healthcare Limited
Listed company · ISIN INE661T01029 · NSE EQ · FV ₹1
Last price
₹735
-5.12%today
What this company does
Paras Healthcare Limited is a listed company. It booked ₹511 cr of revenue in its latest quarter (Q2 FY27) and kept 7.9% of sales as profit.
Is this company doing well?
not investment adviceA mixed picture
Strengths
✓ Makes a profit
✓ Strong 33% return on equity
✓ Turns profit into real cash
Watch-outs
! Thin 7.9% net margin
! Carries high debt (D/E 2.0)
What if I invest in PARASHLTH?
Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.
You would put in
₹12.00 lakh
120 instalments
At 10% a year, it would become
₹20.15 lakh
The starting rate is a round number, not a view on this company — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.
Key ratios · latest quarter + price
₹735▼ -5.12%
latest close · 2026-11-06
52-wk low ₹7068 sessions so far52-wk high ₹794
Is it cheap or expensive?
What you pay for the profits, book value and cash flow. Higher isn't automatically worse — it can signal faster growth.
P/E ratio45.9High
LowAverageHigh
P/B ratio15.26High
Below bookModerateHigh
EV / EBITDA16.5High
LowAverageHigh
How good is the business?
How much profit it earns from its money and its sales.
Return on equity33.2%Strong
WeakFairStrong ▸15%
Return on capital23.8%Strong
WeakFairStrong
Net margin7.9%Decent
ThinDecentStrong
EBITDA margin24.8%Healthy
ThinDecentHealthy
Is it financially safe?
How much it owes, and whether it can comfortably cover it.
Debt to equity2.01High
LowModerateHigh ▸1
Interest cover2.6×Okay
RiskyOkayStrong ▸5×
Current ratio1.14Healthy
Tight ◂1HealthyAmple
More figures
Market cap
₹7,418 cr
Book value
₹48
EPS
₹4.00
latest quarter
Net debt
₹934 cr
owes more than its cash
Enterprise value
₹8,353 cr
EBITDA
₹507 cr
annualised
EBIT
₹352 cr
annualised
Operating margin
17.2%
Return on assets
7.0%
Earnings yield
2.18%
P/S
3.63
Sales / share
₹202.4
Tax rate
25.6%
Face value
₹1
Shares
10.1 cr
Working capital
₹113 cr
Current assets
₹949 cr
Current liabilities
₹836 cr
Delivery %
41.2%
Strong / safeFairWeak / riskyValuation — a level, not good/badBands are general rules of thumb, not advice.
P/E, ROE, ROCE and margins are annualised from the latest quarter; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-11-06.
P&L · Q2 FY27 (consolidated)
| Revenue from Operations | ₹511 cr |
| Other Income | ₹6 cr |
| Total Income | ₹517 cr |
| Cost of Materials | ₹0 cr |
| Purchases of Stock-in-Trade | ₹126 cr |
| Inventory Change (±) | ₹-3 cr |
| Employee Benefit Expense | ₹58 cr |
| Finance Costs | ₹34 cr |
| Depreciation & Amortisation | ₹39 cr |
| Other Expenses | ₹210 cr |
| Total Expenses | ₹463 cr |
| Profit before Tax | ₹54 cr |
| Tax Expense | ₹14 cr |
| Net Profit | ₹40 cr |
| Net margin on total income | 7.8% |
Where the money goes · Q2 FY27
% of total income
Materials + stock-in-trade₹123 cr23.8%
Employee benefit expense₹58 cr11.1%
Finance costs₹34 cr6.5%
Depreciation & amortisation₹39 cr7.5%
Other expenses₹210 cr40.6%
Tax expense₹14 cr2.7%
Profit for the period₹40 cr7.8%
Total income ₹517 cradds up to ₹100 ✓
Balance sheet & cash flow · as of Sep 2026
High debt
Total assets
₹2,316 cr
Shareholder equity
₹486 cr
parent shareholders
Total debt
₹979 cr
Cash
₹45 cr
Cash flow · H1 FY27
Operating
₹68 cr
Investing
₹-134 cr
Financing
₹63 cr
How the stock has moved · adjusted for splits & bonuses
Data from primary exchange filings · analysis tool, not investment advice.